Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2022

May 5, 2022

31461_dirs_2022-05-05_bc143721-6625-4092-bf01-adcd582a95b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2022-05-03

Reporting Person: Ritter Geralyn S (Hd of Ext. Affairs and ESG)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-05-03 Common Stock M 684 Acquired 3987 Direct
2022-05-03 Common Stock F 235 $32.08 Disposed 3752 Direct
2022-05-04 Common Stock M 1939 Acquired 5691 Direct
2022-05-04 Common Stock F 665 $32.44 Disposed 5026 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-03 Restricted Stock Units $ M 684 Disposed 2022-05-03 Common Stock (684) Direct
2022-05-04 Restricted Stock Units $ M 1939 Disposed 2024-05-04 Common Stock (1939) Direct

Footnotes

F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.

F2: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024.